- Telehealth Visits
Lauren Shin, MD
She | Her | HersNeurologyOn this page
About me
Dr. Lauren Shin is a pediatric neurologist who cares for patients with chronic headaches and other neurological conditions.
Shin's research focuses on expanding safe and effective treatment options for pediatric patients with headache disorders as well as on understanding other episodic childhood conditions related to migraine. In 2024, she received a Frontiers in Headache Research Scholarship Award from the American Headache Society.
Shin earned her medical degree at Drexel University College of Medicine. She completed a residency in pediatrics at Tufts Medical Center, followed by a residency in pediatric neurology at Boston Children's Hospital. She completed a fellowship in headache medicine at UCSF.
Shin is fluent in Korean. Outside of work, she enjoys trying new restaurants and cuisines, traveling, going to concerts, drawing, and a "healthy dose" of reality TV shows.
Education
Board Certification
- Neurology with Special Qualification in Child Neurology, American Board of Psychiatry/Neurology-Neurology
Fellowship
- Pediatric Headache - Neurology, UCSF School of Medicine -GME
Residency
- Pediatric Neurology, Boston Children's Hospital
- Child Neurology, Tufts Medical Center
Internship
- Pediatrics, Tufts University School of Medicine - Boston
School
- MD, Drexel University College of Medicine
Academic Title
- Health Sciences Clinical Professor
Care Keywords
Services
- Neurology
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.